Haloub, Radi and Reynolds, Paul Lewis (2010) Pharmerging Countries in the Middle East: a Spotlight on Jordan. In: 3rd annual Pharma Forecasting Excellence 2010, October 2010, Boston - USA. (Unpublished)

The pharmaceutical industry is considered the most growing business. It has a huge profit margin and high investment in Research and Development to create new products to treat new diseases in addition to high investment in the marketing projects and sales power.
Objectives – there are three main objectives of this paper: first purpose is to examine the globalisation in the pharmaceutical business, second purpose is to examine the opportunities in the Middle East pharmaceutical markets as a Pharmerging market and the third purpose is to examine the Jordanian pharmaceutical market as a future emerging market from a strategic point of view. The authors analyse the advantage / disadvantage ratio to penetrate the pharmaceutical Jordanian market. The authors suggest that penetrating Jordanian pharmaceutical market could be the gate to the whole Middle East region.
Purpose: is to provide information for the pharmaceutical companies the latest data about the Pharmerging countries in the Middle East and long-term strategic decision in the region.
Originality / Value – the article addresses the strategic importance for the pharmaceutical companies to consider when penetrating the MENA countries (Middle East and North Africa)

Pharmf.pdf - Accepted Version

Download (782kB) | Preview
Restricted to Repository staff only

Download (581kB)


Downloads per month over past year

Add to AnyAdd to TwitterAdd to FacebookAdd to LinkedinAdd to PinterestAdd to Email